174 related articles for article (PubMed ID: 22126971)
1. Spheroid assay to measure TGF-β-induced invasion.
Naber HP; Wiercinska E; Ten Dijke P; van Laar T
J Vis Exp; 2011 Nov; (57):. PubMed ID: 22126971
[TBL] [Abstract][Full Text] [Related]
2. The TGF-β/Smad pathway induces breast cancer cell invasion through the up-regulation of matrix metalloproteinase 2 and 9 in a spheroid invasion model system.
Wiercinska E; Naber HP; Pardali E; van der Pluijm G; van Dam H; ten Dijke P
Breast Cancer Res Treat; 2011 Aug; 128(3):657-66. PubMed ID: 20821046
[TBL] [Abstract][Full Text] [Related]
3. Studying TGF-β Signaling and TGF-β-induced Epithelial-to-mesenchymal Transition in Breast Cancer and Normal Cells.
Zhang J; Thorikay M; van der Zon G; van Dinther M; Ten Dijke P
J Vis Exp; 2020 Oct; (164):. PubMed ID: 33191940
[TBL] [Abstract][Full Text] [Related]
4. Specific interactions between Smad proteins and AP-1 components determine TGFβ-induced breast cancer cell invasion.
Sundqvist A; Zieba A; Vasilaki E; Herrera Hidalgo C; Söderberg O; Koinuma D; Miyazono K; Heldin CH; Landegren U; Ten Dijke P; van Dam H
Oncogene; 2013 Aug; 32(31):3606-15. PubMed ID: 22926518
[TBL] [Abstract][Full Text] [Related]
5. Smad-binding defective mutant of transforming growth factor beta type I receptor enhances tumorigenesis but suppresses metastasis of breast cancer cell lines.
Tian F; Byfield SD; Parks WT; Stuelten CH; Nemani D; Zhang YE; Roberts AB
Cancer Res; 2004 Jul; 64(13):4523-30. PubMed ID: 15231662
[TBL] [Abstract][Full Text] [Related]
6. Transforming growth factor-β-induced epithelial-mesenchymal transition facilitates epidermal growth factor-dependent breast cancer progression.
Wendt MK; Smith JA; Schiemann WP
Oncogene; 2010 Dec; 29(49):6485-98. PubMed ID: 20802523
[TBL] [Abstract][Full Text] [Related]
7. Transforming growth factor beta signaling is disabled early in human endometrial carcinogenesis concomitant with loss of growth inhibition.
Parekh TV; Gama P; Wen X; Demopoulos R; Munger JS; Carcangiu ML; Reiss M; Gold LI
Cancer Res; 2002 May; 62(10):2778-90. PubMed ID: 12019154
[TBL] [Abstract][Full Text] [Related]
8. BMP-7 inhibits TGF-β-induced invasion of breast cancer cells through inhibition of integrin β(3) expression.
Naber HP; Wiercinska E; Pardali E; van Laar T; Nirmala E; Sundqvist A; van Dam H; van der Horst G; van der Pluijm G; Heckmann B; Danen EH; Ten Dijke P
Cell Oncol (Dordr); 2012 Feb; 35(1):19-28. PubMed ID: 21935711
[TBL] [Abstract][Full Text] [Related]
9. Transforming growth factor-β signalling controls human breast cancer metastasis in a zebrafish xenograft model.
Drabsch Y; He S; Zhang L; Snaar-Jagalska BE; ten Dijke P
Breast Cancer Res; 2013 Nov; 15(6):R106. PubMed ID: 24196484
[TBL] [Abstract][Full Text] [Related]
10. Alterations of Smad signaling in human breast carcinoma are associated with poor outcome: a tissue microarray study.
Xie W; Mertens JC; Reiss DJ; Rimm DL; Camp RL; Haffty BG; Reiss M
Cancer Res; 2002 Jan; 62(2):497-505. PubMed ID: 11809701
[TBL] [Abstract][Full Text] [Related]
11. Therapeutic targeting of the focal adhesion complex prevents oncogenic TGF-beta signaling and metastasis.
Wendt MK; Schiemann WP
Breast Cancer Res; 2009; 11(5):R68. PubMed ID: 19740433
[TBL] [Abstract][Full Text] [Related]
12. Genetic depletion and pharmacological targeting of αv integrin in breast cancer cells impairs metastasis in zebrafish and mouse xenograft models.
Li Y; Drabsch Y; Pujuguet P; Ren J; van Laar T; Zhang L; van Dam H; Clément-Lacroix P; Ten Dijke P
Breast Cancer Res; 2015 Feb; 17(1):28. PubMed ID: 25849225
[TBL] [Abstract][Full Text] [Related]
13. Regulation of transforming growth factor-beta signaling.
Zhu HJ; Burgess AW
Mol Cell Biol Res Commun; 2001 Nov; 4(6):321-30. PubMed ID: 11703090
[TBL] [Abstract][Full Text] [Related]
14. Transforming growth factor beta-induced Smad1/5 phosphorylation in epithelial cells is mediated by novel receptor complexes and is essential for anchorage-independent growth.
Daly AC; Randall RA; Hill CS
Mol Cell Biol; 2008 Nov; 28(22):6889-902. PubMed ID: 18794361
[TBL] [Abstract][Full Text] [Related]
15. Endoglin expression in breast tumor cells suppresses invasion and metastasis and correlates with improved clinical outcome.
Henry LA; Johnson DA; Sarrió D; Lee S; Quinlan PR; Crook T; Thompson AM; Reis-Filho JS; Isacke CM
Oncogene; 2011 Mar; 30(9):1046-58. PubMed ID: 21042283
[TBL] [Abstract][Full Text] [Related]
16. Transforming growth factor-β signalling: role and consequences of Smad linker region phosphorylation.
Kamato D; Burch ML; Piva TJ; Rezaei HB; Rostam MA; Xu S; Zheng W; Little PJ; Osman N
Cell Signal; 2013 Oct; 25(10):2017-24. PubMed ID: 23770288
[TBL] [Abstract][Full Text] [Related]
17. Determining TGF-β Receptor Levels in the Cell Membrane.
Zhang L; Zhou F; van Dinther M; Ten Dijke P
Methods Mol Biol; 2016; 1344():35-47. PubMed ID: 26520116
[TBL] [Abstract][Full Text] [Related]
18. TLR4 ligand/H₂O₂ enhances TGF-β1 signaling to induce metastatic potential of non-invasive breast cancer cells by activating non-Smad pathways.
Zhou YH; Liao SJ; Li D; Luo J; Wei JJ; Yan B; Sun R; Shu Y; Wang Q; Zhang GM; Feng ZH
PLoS One; 2013; 8(5):e65906. PubMed ID: 23734265
[TBL] [Abstract][Full Text] [Related]
19. PDGF receptor-α promotes TGF-β signaling in hepatic stellate cells via transcriptional and posttranscriptional regulation of TGF-β receptors.
Liu C; Li J; Xiang X; Guo L; Tu K; Liu Q; Shah VH; Kang N
Am J Physiol Gastrointest Liver Physiol; 2014 Oct; 307(7):G749-59. PubMed ID: 25169976
[TBL] [Abstract][Full Text] [Related]
20. Sustained activation of SMAD3/SMAD4 by FOXM1 promotes TGF-β-dependent cancer metastasis.
Xue J; Lin X; Chiu WT; Chen YH; Yu G; Liu M; Feng XH; Sawaya R; Medema RH; Hung MC; Huang S
J Clin Invest; 2014 Feb; 124(2):564-79. PubMed ID: 24382352
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
